Tigecycline
Top View
- UK-VARSS 2018 Supplementary Material
- The Efficacy and Safety of Tigecycline for the Treatment of Complicated
- Tigecycline and Comparator Activity Against S. Agalactiae Collected from the TEST Program (2010-2012) 2122 Palmer Dr
- Recommendations for Anti-Microbial Use for Secondary Infections in Patients with COVID-19 Rapid Review
- Tygacil® (Tigecycline) for Injection
- Tigecycline-Amikacin Combination Effectively Suppresses the Selection of Resistance in Clinical Isolates of KPC-Producing Klebsiella Pneumoniae
- TYGACIL (Tigecycline) Is a Tetracycline Derivative (A Glycylcycline) for Intravenous Infusion
- Tigecycline (Tygacil®) (Tygacil®)
- Antibiotic Considerations in the Treatment of Multidrug-Resistant (MDR) Pathogens: a Case-Based Review
- Clinical Efficacy and Adverse Effects of Antibiotics Used to Treat
- ANTIBIOTIC RESISTANCE THREATS in the United States, 2013
- Treatment of Mycobacterium Abscessus Infection
- Synergistic Antibacterial Effect of Casein-Agnps Combined with Tigecycline Against Acinetobacter Baumannii
- Controlled Release of Vancomycin and Tigecycline from an Orthopaedic Implant Coating Prevents Staphylococcus Aureus Infection in an Open Fracture Animal Model
- Tigecycline Exhibits Inhibitory Activity Against Clostridium Difficile in The
- Drug Resistance Updates 40 (2018) 25–39
- Doxycycline and Tigecycline: Two Friendly Drugs with a Low Association with Clostridium Difficile Infection
- Supplementary Material UK-VARSS 2019